Compound comparison
A structured research comparison between Semax and Noopept across compound identity, research category, evidence maturity, and interpretation boundaries.
ACTH-fragment-derived neuropeptide
Investigated across neurotrophic, transcriptional, and stress-response signaling; no single mechanism explains the full literature.
Early human evidence
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
Dipeptide-like neuropharmacology compound
Investigated in cognition and neuroprotection models through mechanisms that should not be collapsed into peptide signaling.
Preclinical foundation
The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.
| Dimension | Semax | Noopept |
|---|---|---|
| Catalog identity | Semax is mapped to ACTH-fragment-derived neuropeptide research. | Noopept is mapped to dipeptide-like neuropharmacology. |
| Research category | Semax is primarily organized around neuroprotection and cognition research. | Noopept is primarily organized around cognition and neuroprotection models. |
| Interpretive boundary | Use the Semax profile and verified study pages before inferring mechanism or outcomes. | Use the Noopept profile and verified study pages before inferring mechanism or outcomes. |
Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.
Semax literature index
PubMed, U.S. National Library of Medicine · Database
Atlas internal research database
Internal Research Database · 2026 · Database
Noopept literature index
PubMed, U.S. National Library of Medicine · Database
Continue the research map